Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients

References

• MuntnerPHeJCutlerJATrends in blood pressure among children and adolescentsJAMA20042912107221315126439
   PubMed Web of Science ®Google Scholar
• WiesenJAdkinsMFortuneSEvaluation of pediatric patients with mild-to-moderate hypertension: yield of diagnostic testingPediatrics2008122e993e998
   Web of Science ®Google Scholar
• UrbinaEAlpertBFlynnJAmbulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure ResearchHypertension20085243345118678786
   PubMed Web of Science ®Google Scholar
• FlynnJTPediatric hypertension updateCurr Opin Nephrol Hypertens20101929229720164767
   PubMed Web of Science ®Google Scholar
• National high blood pressure education program working group on high blood pressure in children and adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescentsPediatrics200411455557615286277
   PubMed Web of Science ®Google Scholar
• ProulxFLacroixJFarrellCAGauthierMConvulsions and hypertension in children: differentiating cause from effectCrit Care Med199321154115468403965
   PubMed Web of Science ®Google Scholar
• CalhounDAOparilSTreatment of hypertensive crisisN Engl J Med1990323117711832215596
   PubMed Web of Science ®Google Scholar
• MiyashitaYPetersonDReesJMFlynnJTIsradipine for treatment of acute hypertension in hospitalized patients and adolescentsJ Clin Hypertens201012850855
   Web of Science ®Google Scholar
• YiuVOrrbineERosychukRJThe safety and use of short-acting nifedipine in hospitalized hypertensive childrenPediatr Nephrol20041964465015054645
   PubMed Web of Science ®Google Scholar
• van HartenJBurggraffKDanhofMNegligible sublingual absorption of nifedipineLancet19872136313652890954
   PubMed Web of Science ®Google Scholar
• SacksFMSvelkeyLPVollmerWMEffects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH Sodium Collaborative Research GroupN Engl J Med200134431011136953
   PubMed Web of Science ®Google Scholar
• EganBMZhaoYAxonRNUS trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008JAMA20103032043205020501926
   PubMed Web of Science ®Google Scholar
• JuliusSNesbittSDEganBMFeasibility of treating prehypertension with an angiotensin receptor blockerN Engl J Med20063541685169716537662
   PubMed Web of Science ®Google Scholar
• CouchSCDanielsSRDiet and blood pressure in childrenCurr Opin Pediatr20051764264716160541
   PubMed Web of Science ®Google Scholar
• KotchenTAObesity-related hypertensionAm J Hypertens2010231170117820706196
   PubMed Web of Science ®Google Scholar
• BlumenthalJABabyakMASherwoodAeffects of the dietary approaches to stop hypertension diet alone in combination with exercise and caloric restriction on insulin sensitivity and lipidsHypertension2010551199120520212264
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension2003421206125214656957
   PubMed Web of Science ®Google Scholar
• WrightJTJrDunnJKCutlerJAOutcomes of hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinoprilJAMA20052931595160815811979
   PubMed Web of Science ®Google Scholar
• WrightJTJrBakrisGGreeneTeffect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJAMA20022882421243112435255
   PubMed Web of Science ®Google Scholar
• ChapmanNChenCYFujitaTTime to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertensionJ Hypertens2010281796180320543713
   PubMed Web of Science ®Google Scholar
• ErnstMELundBCRenewed interest in chlorthalidone: evidence from the Veterans Health AdministrationJ Clin Hypertens201012927934
   PubMed Web of Science ®Google Scholar
• ReungjuiSHuHMuWThiazide-induced subtle renal injury not observed in states of equivalent hypokalemiaKidney Int2007721483149217928827
   PubMed Web of Science ®Google Scholar
• FlackJMSicaDABakrisGManagement of high blood pressure in Blacks: an update of the International Society of Hypertension in Blacks consensus statementHypertension20105678080020921433
   PubMed Web of Science ®Google Scholar
• WangYCCheungAMBibbins-DomingoKEffectiveness and cost-effectiveness of blood pressure screening in adolescents in the United StatesJ Pediatr201115825726420850759
   PubMed Web of Science ®Google Scholar
• FlynnJTNewburgerJWDanielsSRA randomized, placebo-controlled trial of amlodipine in children with hypertensionJ Pediatr200414535335915343191
   PubMed Web of Science ®Google Scholar
• FlynnJTNahataMCMahanJDJrPortmanRJPopulation pharmacokinetics of amlodipine in hypertensive children and adolescentsJ Clin Pharmacol20064690591616855075
   PubMed Web of Science ®Google Scholar
• The ESCAPE Trial GroupStrict blood-pressure control and progression of renal failure in childrenN Engl J Med20093611639165019846849
   PubMed Web of Science ®Google Scholar
• AppelLJWrightJTJrGreeneTIntensive blood-pressure control in hypertensive chronic kidney diseaseN Engl J Med201036391892920818902
   PubMed Web of Science ®Google Scholar
• BidaniAKGriffinKAPathophysiology of hypertensive renal damage: implications for therapyHypertension20044459560115452024
   PubMed Web of Science ®Google Scholar
• RuggenentiPAngiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathiesSemin Nephrol20042415816715017528
   PubMed Web of Science ®Google Scholar
• HouFFZhouQGOptimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotectionNephrology201015Suppl 2576020586951
   PubMed Web of Science ®Google Scholar
• MaJWeisbergAGriffinJPPlasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injuryKidney Int2006691064107216528256
   PubMed Web of Science ®Google Scholar
• PittBZannadFRemmeWJCodyRthe effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation StudyN Engl J Med199934170971710471456
   PubMed Web of Science ®Google Scholar
• WellsTFrameVSofferBA double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertensionJ Clin Pharmacol20024287088012162469
   PubMed Web of Science ®Google Scholar
• WuhlEMehlsOSchaefferFAntihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failureKidney Int20046676877615253732
   PubMed Web of Science ®Google Scholar
• Baker-SmithCNMBenjaminDKJrCaliffRMCough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized clinical trialClin Pharm Therap201087668671
   PubMed Web of Science ®Google Scholar
• CicardiMZingaleLCBergamaschiniLAgostoniAAngioedema associated with angiotensin-converting enzyme inhibitor useArch Int Med200416491091315111379
   PubMed Web of Science ®Google Scholar
• PalmerBFRenal dysfunction complicating treatment of hypertensionN Eng J Med200234712561261
   PubMed Web of Science ®Google Scholar
• BakrisGLWeirMRComparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progressionPostgrad Med20081210334218467807
   PubMed Web of Science ®Google Scholar
• PalmerBFManaging hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone systemN Eng J Med2004351585592
   PubMed Web of Science ®Google Scholar
• CooperWOHernandez-DiazSArbogastPGMajor congenital malformations after first trimester exposure to ACE inhibitorsN Engl J Med20063542443245116760444
   PubMed Web of Science ®Google Scholar
• PetrieMCPadmanabhanNMcDonaldJEAngiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart diseaseJ Am Coll Cardiol2001371056106111263608
   PubMed Web of Science ®Google Scholar
• HirataKVlachopoulosaCAdjiAO’RourkeMFBenefits from angiotensin converting enzyme inhibitor “beyond blood pressure lowering”: beyond blood pressure or beyond the brachial arteryJ Hypertens20052355155615716696
   PubMed Web of Science ®Google Scholar
• MatcharDBMcCroryDCOrlandoLASystematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of essential hypertensionAnn Int Med2008148162917984484
   PubMed Web of Science ®Google Scholar
• NorrisSWeinsteinJPetersonKThakurtaSDirect renin inhibitors, angiotensin converting enzyme inhibitors, and angiotensin II receptor blockers: final reportDrug Class ReviewsPortland, OROregon Health and Science University2010
   Google Scholar
• MendeCWApplication of direct renin inhibition to chronic kidney diseaseCardiovasc Drug Ther201024139149
   Web of Science ®Google Scholar
• GrossOGirgertRRubelDRenal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosisAm J Hypertens201124335536121127470
   PubMed Web of Science ®Google Scholar
• NathanSPepineCJBakrisGLCalcium antagonists: effects on cardiorenal risk in hypertensive patientsHypertension20054663764216172420
   PubMed Web of Science ®Google Scholar
• SarafidisPAKhosiaNBakrisGLAntihypertensive therapy in the presence of proteinuriaAm J Kid Dis200749122617185142
   PubMed Web of Science ®Google Scholar